100 related articles for article (PubMed ID: 15546202)
21. Synthesis and antitumor activities of water-soluble benzoylphenylureas.
Okada H; Kato M; Koyanagi T; Mizuno K
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):430-3. PubMed ID: 10212393
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, antitumor activity, and nephrotoxicity of the optical isomers of 2-aminomethylpyrrolidine(1,1-cyclobutane-dicarboxylato)platinum(II).
Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
J Pharm Sci; 1991 Sep; 80(9):837-42. PubMed ID: 1800705
[TBL] [Abstract][Full Text] [Related]
23. Cytosine arabinoside prodrug designed to bind plasma serum albumin for drug delivery.
Wei W; He Z; Yang J; Sun M; Sun J
Drug Deliv Transl Res; 2018 Oct; 8(5):1162-1170. PubMed ID: 29748833
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antitumor activities of amino acid prodrugs of amino-combretastatins.
Ohsumi K; Hatanaka T; Nakagawa R; Fukuda Y; Morinaga Y; Suga Y; Nihei Y; Ohishi K; Akiyama Y; Tsuji T
Anticancer Drug Des; 1999 Dec; 14(6):539-48. PubMed ID: 10834274
[TBL] [Abstract][Full Text] [Related]
25. Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.
Helsby NA; Atwell GJ; Yang S; Palmer BD; Anderson RF; Pullen SM; Ferry DM; Hogg A; Wilson WR; Denny WA
J Med Chem; 2004 Jun; 47(12):3295-307. PubMed ID: 15163209
[TBL] [Abstract][Full Text] [Related]
26. Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy.
Davies LC; Friedlos F; Hedley D; Martin J; Ogilvie LM; Scanlon IJ; Springer CJ
J Med Chem; 2005 Aug; 48(16):5321-8. PubMed ID: 16078849
[TBL] [Abstract][Full Text] [Related]
27. Design, modeling, synthesis and biological activity evaluation of camptothecin-linked platinum anticancer agents.
Cincinelli R; Musso L; Dallavalle S; Artali R; Tinelli S; Colangelo D; Zunino F; De Cesare M; Beretta GL; Zaffaroni N
Eur J Med Chem; 2013 May; 63():387-400. PubMed ID: 23517728
[TBL] [Abstract][Full Text] [Related]
28. Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs.
Johnstone TC; Alexander SM; Wilson JJ; Lippard SJ
Dalton Trans; 2015 Jan; 44(1):119-29. PubMed ID: 25367395
[TBL] [Abstract][Full Text] [Related]
29. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs.
Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH
Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806
[TBL] [Abstract][Full Text] [Related]
30. Development of protein-binding bifunctional linkers for a new generation of dual-acting prodrugs.
Abu Ajaj K; Biniossek ML; Kratz F
Bioconjug Chem; 2009 Feb; 20(2):390-6. PubMed ID: 19199576
[TBL] [Abstract][Full Text] [Related]
31. Investigation of in vitro anticancer and DNA strap interactions in live cells using carboplatin type Cu(II) and Zn(II) metalloinsertors.
Pravin N; Raman N
Eur J Med Chem; 2014 Oct; 85():675-87. PubMed ID: 25128669
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
[TBL] [Abstract][Full Text] [Related]
34. Therapy-induced carboplatin-DNA adduct levels in human ovarian tumours in relation to assessment of adduct measurement in mouse tissues.
Jarvis IW; Meczes EL; Thomas HD; Edmondson RJ; Veal GJ; Boddy AV; Ottley CJ; Pearson DG; Tilby MJ
Biochem Pharmacol; 2012 Jan; 83(1):69-77. PubMed ID: 22015635
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a potent tubulin polymerization inhibitor: synthesis and evaluation of water-soluble prodrugs of benzophenone analog.
Lee J; Bae S; Lee SH; Choi H; Kim YH; Kim SJ; Park GT; Moon SK; Kim DH; Lee S; Ahn SK; Choi NS; Lee KJ
Bioorg Med Chem Lett; 2010 Nov; 20(21):6327-30. PubMed ID: 20850313
[TBL] [Abstract][Full Text] [Related]
36. Significant differences in biological parameters between prodrugs cleavable by carboxypeptidase G2 that generate 3,5-difluoro-phenol and -aniline nitrogen mustards in gene-directed enzyme prodrug therapy systems.
Niculescu-Duvaz I; Scanlon I; Niculescu-Duvaz D; Friedlos F; Martin J; Marais R; Springer CJ
J Med Chem; 2004 May; 47(10):2651-8. PubMed ID: 15115406
[TBL] [Abstract][Full Text] [Related]
37. Glycosyl and polyalcoholic prodrugs of lonidamine.
Giorgioni G; Ruggieri S; Di Stefano A; Sozio P; Cinque B; Di Marzio L; Santoni G; Claudi F
Bioorg Med Chem Lett; 2008 Apr; 18(7):2445-50. PubMed ID: 18321702
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
39. 2-fluoro-5-maleimidobenzoic acid-linked albumin drug (MAD) delivery for selective systemic targeting of metastatic prostate cancer.
Akinboye ES; Rogers OC; Isaacs JT
Prostate; 2018 Jun; 78(9):655-663. PubMed ID: 29572902
[TBL] [Abstract][Full Text] [Related]
40. The anticancer activity and HSA binding properties of the structurally related platinum (II) complexes.
Yousefi R; Aghevlian S; Mokhtari F; Samouei H; Rashidi M; Nabavizadeh SM; Tavaf Z; Pouryasin Z; Niazi A; Faghihi R; Papari MM
Appl Biochem Biotechnol; 2012 Jun; 167(4):861-72. PubMed ID: 22622643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
